Amy Hart

1.9k total citations
22 papers, 448 citations indexed

About

Amy Hart is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Amy Hart has authored 22 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 6 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Amy Hart's work include Inflammatory Bowel Disease (6 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Genetic Associations and Epidemiology (4 papers). Amy Hart is often cited by papers focused on Inflammatory Bowel Disease (6 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Genetic Associations and Epidemiology (4 papers). Amy Hart collaborates with scholars based in United States, Spain and United Kingdom. Amy Hart's co-authors include Abraham A. Palmer, Harriet de Wit, Henry R. Kranzler, Margaret C. Wardle, Matthew J. Baggott, Emma Childs, Joy E. Wilkinson, Lide Han, Sandra Sanchez‐Roige and Jianjun Gao and has published in prestigious journals such as Gastroenterology, PLoS ONE and Human Molecular Genetics.

In The Last Decade

Amy Hart

19 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Hart United States 9 113 104 96 92 67 22 448
Silvana Almeida Brazil 18 199 1.8× 115 1.1× 118 1.2× 76 0.8× 46 0.7× 64 807
Aida Cuenca‐Royo Spain 14 100 0.9× 92 0.9× 112 1.2× 84 0.9× 34 0.5× 29 671
Joseph D. Deak United States 10 97 0.9× 48 0.5× 47 0.5× 68 0.7× 49 0.7× 26 290
Andrew J. Schrage United States 7 96 0.8× 109 1.0× 123 1.3× 86 0.9× 69 1.0× 7 345
Ruiling Zhang China 14 46 0.4× 74 0.7× 192 2.0× 90 1.0× 77 1.1× 65 582
Jessica L. Bar United States 5 68 0.6× 108 1.0× 91 0.9× 84 0.9× 29 0.4× 6 466
Amira Pierucci‐Lagha United States 11 113 1.0× 270 2.6× 140 1.5× 214 2.3× 122 1.8× 13 664
Atapol Sughondhabirom Thailand 14 41 0.4× 153 1.5× 68 0.7× 58 0.6× 30 0.4× 24 525
Rasmon Kalayasiri Thailand 17 51 0.5× 218 2.1× 90 0.9× 150 1.6× 53 0.8× 40 588
Mario Páramo Spain 13 93 0.8× 72 0.7× 124 1.3× 27 0.3× 27 0.4× 38 474

Countries citing papers authored by Amy Hart

Since Specialization
Citations

This map shows the geographic impact of Amy Hart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Hart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Hart more than expected).

Fields of papers citing papers by Amy Hart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Hart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Hart. The network helps show where Amy Hart may publish in the future.

Co-authorship network of co-authors of Amy Hart

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Hart. A scholar is included among the top collaborators of Amy Hart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Hart. Amy Hart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allegretti, Jessica R., Raja Atreya, María T. Abreu, et al.. (2024). S1241 Guselkumab Binding to CD64+ IL-23–Producing Myeloid Cells Enhances Potency for Neutralizing IL-23 Signaling. The American Journal of Gastroenterology. 119(10S). S883–S883.
2.
Colombel, Jean‐Frédéric, et al.. (2023). HLA-DQA1*05 Not Associated With Ustekinumab Loss of Response and Antidrug Antibodies in Ulcerative Colitis and Crohn’s Disease Patients. Inflammatory Bowel Diseases. 30(11). 2227–2231. 7 indexed citations
3.
4.
Colombel, Jean‐Frédéric, et al.. (2022). S57 Impact of the HLA-DQA1*05 Allele on Ustekinumab Loss of Response, Anti-drug Antibodies, and Concentration in Patients With Inflammatory Bowel Disease. The American Journal of Gastroenterology. 117(12S). S15–S15. 1 indexed citations
5.
Narzo, Antonio Di, Itziar Frades, Paul K. Crane, et al.. (2021). Meta-analysis of sample-level dbGaP data reveals novel shared genetic link between body height and Crohn’s disease. Human Genetics. 140(6). 865–877. 3 indexed citations
6.
Narzo, Antonio Fabio Di, Amy Hart, Roman Kosoy, et al.. (2021). Polygenic risk score for alcohol drinking behavior improves prediction of inflammatory bowel disease risk. Human Molecular Genetics. 30(6). 514–523. 4 indexed citations
7.
Jacobs, Jonathan P., Elizabeth A. Spencer, Kyle Gettler, et al.. (2021). Sa473 RISK PROFILING OF UNAFFECTED MEMBERS OF FAMILIES WITH A HISTORY OF IBD USING SEROLOGY SCORE, DYSBIOSIS SCORE, POLYGENIC RISK SCORE, AND FECAL CALPROTECTIN. Gastroenterology. 160(6). S–511. 2 indexed citations
8.
9.
Spencer, Elizabeth A., Kyle Gettler, Drew Helmus, et al.. (2019). 03 TOWARDS DISEASE INTERCEPTION: CONTRIBUTION OF POLYGENIC RISK SCORES TOWARDS AGE-DEPENDENT RISK OF IBD IN A HIGH-RISK POPULATION. Gastroenterology. 156(3). S73–S74. 1 indexed citations
10.
Hart, Amy, et al.. (2017). Genome-Wide Association Study of Baseline Disease Characteristics and Response to Ustekinumab in Moderate to Severe Crohn's Disease. Gastroenterology. 152(5). S985–S985. 1 indexed citations
11.
Gao, Jianjun, Lea K. Davis, Amy Hart, et al.. (2016). Genome-Wide Association Study of Loneliness Demonstrates a Role for Common Variation. Neuropsychopharmacology. 42(4). 811–821. 66 indexed citations
12.
Chambliss, Catherine, et al.. (2016). Personality Correlates of Nonclinical Substance use in Adolescents. 4(1). 1 indexed citations
13.
Denis, Cécile, Joel Gelernter, Amy Hart, & Henry R. Kranzler. (2015). Inter-observer reliability of DSM-5 substance use disorders. Drug and Alcohol Dependence. 153. 229–235. 24 indexed citations
14.
Meda, Shashwath A., et al.. (2015). Multivariate analysis of subjective responses to d-amphetamine in healthy volunteers finds novel genetic pathway associations. Psychopharmacology. 232(15). 2781–2794. 7 indexed citations
15.
Hart, Amy & Henry R. Kranzler. (2015). Alcohol Dependence Genetics: Lessons Learned From Genome-Wide Association Studies (GWAS) and Post-GWAS Analyses. Alcoholism Clinical and Experimental Research. 39(8). 1312–1327. 79 indexed citations
16.
Baggott, Matthew J., Emma Childs, Amy Hart, et al.. (2013). Psychopharmacology of theobromine in healthy volunteers. Psychopharmacology. 228(1). 109–118. 73 indexed citations
17.
Hart, Amy, Harriet de Wit, & Abraham A. Palmer. (2012). Candidate Gene Studies of a Promising Intermediate Phenotype: Failure to Replicate. Neuropsychopharmacology. 38(5). 802–816. 54 indexed citations
18.
Wardle, Margaret C., Amy Hart, Abraham A. Palmer, & Harriet de Wit. (2012). Does COMT genotype influence the effects of d‐amphetamine on executive functioning?. Genes Brain & Behavior. 12(1). 13–20. 20 indexed citations
19.
Hart, Amy, Barbara E. Engelhardt, Margaret C. Wardle, et al.. (2012). Genome-Wide Association Study of d-Amphetamine Response in Healthy Volunteers Identifies Putative Associations, Including Cadherin 13 (CDH13). PLoS ONE. 7(8). e42646–e42646. 58 indexed citations
20.
Hart, Amy, Harriet de Wit, & Abraham A. Palmer. (2011). Genetic Factors Modulating the Response to Stimulant Drugs in Humans. Current topics in behavioral neurosciences. 12. 537–577. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvana Almeida Breakdown of academic impact, for papers by Aida Cuenca‐Royo Breakdown of academic impact, for papers by Joseph D. Deak Breakdown of academic impact, for papers by Andrew J. Schrage Breakdown of academic impact, for papers by Ruiling Zhang Breakdown of academic impact, for papers by Jessica L. Bar Breakdown of academic impact, for papers by Amira Pierucci‐Lagha Breakdown of academic impact, for papers by Atapol Sughondhabirom Breakdown of academic impact, for papers by Rasmon Kalayasiri Breakdown of academic impact, for papers by Mario Páramo
Rankless by CCL
2026